Skip to main content
Chabiotech Co.,Ltd. logo

Chabiotech Co.,Ltd. — Investor Relations & Filings

Ticker · 085660 ISIN · KR7085660009 KO Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2025-03-19 Capital/Financing Update
Country KR South Korea
Listing KO 085660

About Chabiotech Co.,Ltd.

http://en.chabio.com/

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Recent filings

Filing Released Lang Actions
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Cha Biotech regarding the acquisition of bonds before maturity (specifically, bonds with warrants). It details the bond series, acquisition amount, reason for acquisition (put option exercise), and the method of acquisition. This falls under capital structure changes and financing updates, specifically related to debt management and capital adjustments. Given the specific nature of bond buybacks/acquisitions, it fits best under the 'CAP' (Capital/Financing Update) category.
2025-03-19 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a 'Solicitation of Proxy' (의결권대리행사권유참고서류) for an upcoming Annual General Meeting (AGM). It contains details about the proxy solicitor, the purpose of the solicitation, and the agenda items for the meeting, including financial statements. While it contains financial data, the primary purpose of the document is to solicit proxies for the shareholder meeting, which falls under the Proxy Solicitation category.
2025-03-17 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (AGM) for the company 'Cha Biotech'. It details the date, location, and specific agenda items (proposals) to be voted on by shareholders, including the election of directors, auditors, and amendments to the articles of incorporation. This type of document is a standard proxy solicitation and information statement provided to shareholders prior to a meeting to request their votes.
2025-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Cha Biotech, scheduled for March 31, 2025. It includes the meeting agenda, details on voting procedures, and management reference materials (such as director activity reports and transaction details). This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the upcoming AGM and solicit their participation/votes. In the provided taxonomy, this fits best under 'Proxy Solicitation & Information Statement' (PSI).
2025-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement) for Cha Biotech. It contains detailed information regarding the solicitation of proxies for the upcoming Annual General Meeting (AGM), including the purpose of the solicitation, information about the solicitor, and instructions for shareholders to exercise their voting rights via electronic or written proxy. This document is a standard proxy solicitation material sent to shareholders to request votes for an upcoming meeting.
2025-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Proxy Solicitation of Voting Rights). It is a formal document issued by CHA Biotech to shareholders, providing information about the upcoming Annual General Meeting (AGM), including the purpose of the meeting, details on proxy solicitation, and information on the board's proposals. This document is a standard proxy statement used to solicit votes for a shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.